Shattuck Labs, Inc.: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 10, 2021 and accepted by EDGAR at May 10, 2021, 16:55 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $2.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2021-01-01 to 2021-03-31 | $10.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-01-01 to 2021-03-31 | −$12.4m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2021-01-01 to 2021-03-31 | −$11.8m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2021-01-01 to 2021-03-31 | −$11.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-01-01 to 2021-03-31 | $2.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-03-31 | $84.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $331.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $336.9m | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $17.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $38.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-03-31 | $298.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001680367-21-000017. Last ingested by Listed: Nov 5, 2026, 12:15 ET. Listed shows no prices and gives no investment advice.